Trending News
News
News
GSK Extends GeneGo License and Adds new Products
This will provide GSK researchers in Bioinformatics, R&D and clinical studies with global access to MetaCore, MapEditor and MetaBase.
News
Chemical Signature of Manic Depression Discovered by Scientists
People with manic depression have a distinct chemical signature in their brains, according to a new study.
News
Online Resource for Peptide Chemists
Activotec has announced the launch of an updated information-rich website.
News
Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
Vermillion obtains exclusive rights the development of biomarkers that can be applied toward disease detection, classification and monitoring of prevalent cancers.
News
DiscoveRx Corporation Signs Agreement with Cosmo Bio
DiscoveRx Corporation announces the selection of Cosmo Bio as a key distributor for the Japanese territory.
News
Select Biosciences Announces the Availability of Exhibition-only Passes for Screening, ADMET & MedChem Europe
The event will see over 350 people gathering to attend presentations on the latest on biomolecular screening, medicinal chemistry or ADME-toxicology advances.
News
Amgen and Takeda Announce Exclusive Collaboration in Japan on up to 13 Amgen Clinical Candidates
Under the agreement, Takeda will receive exclusive rights to develop and commercialize select molecules in Japan.
News
Vyteris Announces Redirection of Business towards the Advancement of Peptide Delivery
Vyteris, with approval from its Board of Directors, has redirected its business to focus on the development of peptide delivery using its Smart Patch technology.
News
Archemix Earns Milestone Payment from Initiation of Phase 1 Clinical Trial by Nuvelo
The milestone payment has been triggered by Nuvelo’s enrollment of the first volunteer in a Phase 1 study of NU172, a thrombin-inhibiting aptamer.
News
Oncolytics Biotech Announces Publication of Research on Combination Reovirus and Radiation Therapy
Dr. Kevin Harrington at The Institute of Cancer Research published the results of their work testing combination treatment schedules of reovirus and radiation in human and murine tumor cells in vitro and in vivo.
Advertisement